Unit of Legal Medicine, University of Cantabria, Santander, Spain.
Clin Chim Acta. 2012 Mar 22;413(5-6):548-51. doi: 10.1016/j.cca.2011.11.022. Epub 2011 Nov 29.
The analysis of chimerism after bone marrow transplantation by STR-PCR is frequently carried out with commercial kits designed for forensic purposes and including too many non informative STR. Furthermore, in routine clinical practice it is not uncommon to lack the pre-transplant genotype of the recipient or the donor, thus making it difficult to identify both components in the post-transplant genotype. The objective of this paper is to overcome these drawbacks by analyzing the informativity of STR markers from a perspective which can be applied whether the pretransplant genotypes are available or not, and selecting a minimum STR panel that allows an effective direct detection of chimerism.
DNA extraction, STR-PCR and fragment analysis of 15 STR in 90 donor-recipient pairs, 60 of which were part of the discovery set and 30 in a validation set. Loci were considered as informative when there were 3 or 4 different alleles in the combined genotypes of the recipient and the donor.
The informativity varied between 41.6 and 76.6. The 4 most informative loci were D2S1338, D21S11, D18S51 and FGA. We could select a minimum set of 8 markers (D2S1338, D21S11, D18S51, FGA, VWA, D19S433, TH01 and D3S1358) that provided at least 3 informative loci in 95% of cases.
This minimum STR panel may be an efficient way to detect and quantitate donor-recipient chimerism after transplantation.
通过 STR-PCR 对骨髓移植后的嵌合体进行分析,通常使用专为法医目的设计的商业试剂盒,其中包含过多的非信息性 STR。此外,在常规临床实践中,受体或供体的移植前基因型往往缺失,这使得难以在移植后基因型中识别两者的成分。本文的目的是通过从一种可以应用于是否存在移植前基因型的角度来分析 STR 标记的信息性,克服这些缺点,并选择一个最小的 STR 面板,以允许对嵌合体进行有效的直接检测。
对 90 对供体-受体进行 DNA 提取、STR-PCR 和 15 个 STR 片段分析,其中 60 对为发现集的一部分,30 对为验证集的一部分。当受体和供体的组合基因型中有 3 或 4 个不同的等位基因时,将位点视为信息性的。
信息性在 41.6%至 76.6%之间变化。最具信息性的 4 个位点是 D2S1338、D21S11、D18S51 和 FGA。我们可以选择一个最小的 8 个标记集(D2S1338、D21S11、D18S51、FGA、VWA、D19S433、TH01 和 D3S1358),在 95%的情况下提供至少 3 个信息性位点。
这个最小的 STR 面板可能是一种检测和定量移植后供体-受体嵌合体的有效方法。